Literature DB >> 28656381

Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.

Susana Herrera Lara1, Estrella Fernández-Fabrellas2, Gustavo Juan Samper2, Josefa Marco Buades3, Rafael Andreu Lapiedra4, Amparo Pinilla Moreno3, María Morales Suárez-Varela5,6,7.   

Abstract

BACKGROUND: The usefulness of clinical, radiological and pleural fluid analytical parameters for diagnosing malignant and paramalignant pleural effusion is not clearly stated. Hence this study aimed to identify possible predictor variables of diagnosing malignancy in pleural effusion of unknown aetiology.
METHODS: Clinical, radiological and pleural fluid analytical parameters were obtained from consecutive patients who had suffered pleural effusion of unknown aetiology. They were classified into three groups according to their final diagnosis: malignant, paramalignant and benign pleural effusion. The CHAID (Chi-square automatic interaction detector) methodology was used to estimate the implication of the clinical, radiological and analytical variables in daily practice through decision trees.
RESULTS: Of 71 patients, malignant (n = 31), paramalignant (n = 15) and benign (n = 25), smoking habit, dyspnoea, weight loss, radiological characteristics (mass, node, adenopathies and pleural thickening) and pleural fluid analytical parameters (pH and glucose) distinguished malignant and paramalignant pleural effusions (all with a p < 0.05). Decision tree 1 classified 77.8% of malignant and paramalignant pleural effusions in step 2. Decision tree 2 classified 83.3% of malignant pleural effusions in step 2, 73.3% of paramalignant pleural effusions and 91.7% of benign ones.
CONCLUSIONS: The data herein suggest that the identified predictor values applied to tree diagrams, which required no extraordinary measures, have a higher rate of correct identification of malignant, paramalignant and benign effusions when compared to techniques available today and proved most useful for usual clinical practice. Future studies are still needed to further improve the classification of patients.

Entities:  

Keywords:  Cancer; Diagnosis; Effusion; Malignant; Pleural effusion

Mesh:

Substances:

Year:  2017        PMID: 28656381     DOI: 10.1007/s00408-017-0032-3

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  17 in total

1.  Management of malignant pleural effusions.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

2.  Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010.

Authors:  Clare Hooper; Y C Gary Lee; Nick Maskell
Journal:  Thorax       Date:  2010-08       Impact factor: 9.139

3.  Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions.

Authors:  J E Heffner; P J Nietert; C Barbieri
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

Review 4.  [Diagnosis and treatment of pleural effusion].

Authors:  Victoria Villena Garrido; Jaime Ferrer Sancho; Luis Hernández Blasco; Alicia de Pablo Gafas; Esteban Pérez Rodríguez; Francisco Rodríguez Panadero; Santiago Romero Candeira; Angel Salvatierra Velázquez; Luis Valdés Cuadrado
Journal:  Arch Bronconeumol       Date:  2006-07       Impact factor: 4.872

5.  Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.

Authors:  Luis Valdés; Esther San-José; Lucía Ferreiro; Antonio Golpe; Francisco-Javier González-Barcala; María E Toubes; María X Rodríguez-Álvarez; José M Álvarez-Dobaño; Nuria Rodríguez-Núñez; Carlos Rábade; Francisco Gude
Journal:  Clin Respir J       Date:  2014-03-20       Impact factor: 2.570

6.  Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions.

Authors:  José M Porcel; Marina Pardina; Silvia Bielsa; Antonio González; Richard W Light
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

7.  Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy.

Authors:  Jaume Ferrer; Juan Roldán; Joan Teixidor; Esther Pallisa; Ignasi Gich; Ferran Morell
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

8.  Lung cancer and pleural effusion. Clinical significance and study of pleural metastatic locations.

Authors:  A Cantó; G Ferrer; V Romagosa; J Moya; R Bernat
Journal:  Chest       Date:  1985-05       Impact factor: 9.410

9.  The value of multiple fluid specimens in the cytological diagnosis of malignancy.

Authors:  L W Garcia; B S Ducatman; H H Wang
Journal:  Mod Pathol       Date:  1994-08       Impact factor: 7.842

10.  Combining clinical and analytical parameters improves prediction of malignant pleural effusion.

Authors:  Luis Valdés; Esther San-José; Lucía Ferreiro; Francisco-Javier González-Barcala; Antonio Golpe; José M Álvarez-Dobaño; María E Toubes; Nuria Rodríguez-Núñez; Carlos Rábade; Adriana Lama; Francisco Gude
Journal:  Lung       Date:  2013-10-02       Impact factor: 2.584

View more
  9 in total

1.  How Useful are Clinical Criteria for Diagnosing Malignant, Paramalignant and Benign Pleural Effusions?

Authors:  Daniel E Banks; Sayed Ali
Journal:  Lung       Date:  2017-08-17       Impact factor: 2.584

Review 2.  Treating Recurrent Pleural Disease: A Review of Indications and Technique for Chemical Pleurodesis for the Interventional Radiologist.

Authors:  Surbhi B Trivedi; Matthew Niemeyer
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

Review 3.  Malignant Pleural Effusion and Its Current Management: A Review.

Authors:  Kristijan Skok; Gaja Hladnik; Anja Grm; Anton Crnjac
Journal:  Medicina (Kaunas)       Date:  2019-08-15       Impact factor: 2.948

4.  A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion.

Authors:  Liyan Lin; Shuguang Li; Qiao Xiong; Hui Wang
Journal:  BMC Pulm Med       Date:  2021-03-19       Impact factor: 3.317

5.  Diagnostic accuracy of adenosine deaminase for pleural tuberculosis in a low prevalence setting: A machine learning approach within a 7-year prospective multi-center study.

Authors:  Alberto Garcia-Zamalloa; Diego Vicente; Rafael Arnay; Arantzazu Arrospide; Jorge Taboada; Iván Castilla-Rodríguez; Urko Aguirre; Nekane Múgica; Ladislao Aldama; Borja Aguinagalde; Montserrat Jimenez; Edurne Bikuña; Miren Begoña Basauri; Marta Alonso; Emilio Perez-Trallero
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

6.  Application of endoscopic ultrasound-guided-fine needle aspiration combined with cyst fluid analysis for the diagnosis of mediastinal cystic lesions.

Authors:  Yuchong Zhao; Ronghua Wang; Yun Wang; Qian Chen; Liangkai Chen; Wei Hou; Limin Liu; Wei Gao; Bin Cheng
Journal:  Thorac Cancer       Date:  2018-11-27       Impact factor: 3.500

7.  PleThora: Pleural effusion and thoracic cavity segmentations in diseased lungs for benchmarking chest CT processing pipelines.

Authors:  Kendall J Kiser; Sara Ahmed; Sonja Stieb; Abdallah S R Mohamed; Hesham Elhalawani; Peter Y S Park; Nathan S Doyle; Brandon J Wang; Arko Barman; Zhao Li; W Jim Zheng; Clifton D Fuller; Luca Giancardo
Journal:  Med Phys       Date:  2020-08-28       Impact factor: 4.071

8.  The diagnostic yield of closed needle pleural biopsy in exudative pleural effusion: a retrospective 10-year study.

Authors:  Tianli Zhang; Bing Wan; Li Wang; Chuling Li; Yangyang Xu; Xiangdong Wang; Hongbing Liu; Yong Song; Dang Lin; Ping Zhan; Tangfeng Lv
Journal:  Ann Transl Med       Date:  2020-04

9.  Computed Tomography Morphological Classification of Lung Adenocarcinoma and Its Correlation with Epidermal Growth Factor Receptor Mutation Status: A Report of 1075 Cases.

Authors:  Xiao-Qun He; Xing-Tao Huang; Qi Li; Xiao Fan; Tian-You Luo; Ji-Wen Huo
Journal:  Int J Gen Med       Date:  2021-07-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.